CZH15572 is an early-maturing, white-grain hybrid that has good yield potential under high density and optimum conditions, with good resistance to GLS, TLB and rust. |
|
General Information |
|
Adaptation/Agroecological zone |
600-1500 masl |
|
Region |
Southern Africa |
|
Type of product |
Three-way Cross |
|
|
|
Year first announced |
2017 |
Grain Yield |
|
|
|
Grain yield (MEA) (OPT) |
8.6 t/ha |
|
Grain Characteristics |
Grain yield (MEB) (OPT) |
8.1 t/ha |
|
Grain color |
White |
Grain yield (MEC) (OPT) |
6.0 t/ha |
|
Grain texture |
Semi-dent |
Grain yield (MED) (OPT) |
1.8 t/ha |
|
|
|
Grain yield (MEA) (HD) |
10.4 t/ha |
|
Biotic Stress Performance |
Grain yield under low N stress |
3.1 t/ha |
|
Turcicum leaf blight (TLB) (1-9) |
3.8 |
Grain yield under MSV conditions |
6.8 t/ha |
|
Rust (1-9) |
3.8 |
|
|
|
Maize streak virus (MSV) (1-9) |
1.0 |
Agronomic Characteristics |
|
Grey leaf spot (GLS) (1-9) |
4.4 |
Maturity |
130 DAP |
|
Ear rot |
7.8% |
Anthesis-silking interval |
1.3 Days |
|
Diseases were originally scored on a 1-5 scale but have been converted here to a 1-9 scale, where 1 = Highly resistant; 5 = Tolerant; 9 = Highly susceptible. |
Bad husk cover |
4.3% |
|
Ear aspect |
2.9 |
|
|
|
Ear height |
110 cm |
|
Seed Production Characteristics |
Plant aspect |
2.9 |
|
Female seed yield |
9.2 t/ha |
Plant height |
236 cm |
|
Male seed yield |
2.4 t/ha |
Stalk lodging |
7.0% |
|
Nicking |
0.2 Days |
Plant and ear aspects are scored on 1-5 scale, where 1 = desirable and 5 = undesirable characteristics |
|
|
|
|
Comments |
|
|
|
Product information is based on data from the CIMMYT Southern Africa Maize Regional On-Station 2017 Trials.
Abbreviations:
DAP = Days After Planting
DLL = Dry Lowlands
DMA = Dry Mid-Altitudes
GLS = Grey Leaf Spot
Low N = Managed Low Nitrogen
masl = meters above sea level
MEA = Mega-environment A
MEB= Mega-environment B
MEC = Mega-environment C
MED = Mega-environment D
MSV = Maize Streak Virus
NUE = Nitrogen Use Efficient
TLB = Turcicum Leaf Blight |
Further Links |
|
Full Announcement |
|
Regional Trial Data Summary |
|
Regional Trial Site Information |
|
|
|
|
|
|
|
|
|
|
|
|
|